ClinicalTrialsFinder

deaf-blind Clinical Trials in Durham, North Carolina

1 recruitingDurham, North Carolina

Showing 1–1 of 1 trials

Recruiting
Phase 2

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

deaf-blindRetinitis pigmentosa (RP)Retinal Disease+4 more
Laboratoires Thea81 enrolled27 locationsNCT06627179